原发性肝癌B细胞异位基因2的表达及临床意义

叶云飞; 肖何; 罗佳; 皮国成; 王阁

doi:10.16016/j.1000-5404.201611153

您当前的位置：

首页 >

文章列表页 >

原发性肝癌B细胞异位基因2的表达及临床意义

更新时间：2026-01-09

- 原发性肝癌B细胞异位基因2的表达及临床意义
- Expression and clinical significance of B cell translocation gene 2 in primary hepatocellular carcinoma
- 第三军医大学学报 2017年39卷第7期页码：685-690
- 作者机构：
- 作者简介：
- 基金信息：
  
  国家自然科学基金面上项目(81572959)
- DOI：10.16016/j.1000-5404.201611153
  中图分类号：
- 收稿：2016-11-17，
  
  纸质出版：2017-07
- 稿件说明：
移动端阅览
叶云飞, 肖何, 罗佳, 等. 原发性肝癌B细胞异位基因2的表达及临床意义[J]. 第三军医大学学报, 2017,39(7):685-690.

Yunfei Ye, He Xiao, Jia Luo, et al. Expression and clinical significance of B cell translocation gene 2 in primary hepatocellular carcinoma[J]. Journal of Third Military Medical University, 2017, 39(7): 685-690.
叶云飞, 肖何, 罗佳, 等. 原发性肝癌B细胞异位基因2的表达及临床意义[J]. 第三军医大学学报, 2017,39(7):685-690. DOI： 10.16016/j.1000-5404.201611153.

Yunfei Ye, He Xiao, Jia Luo, et al. Expression and clinical significance of B cell translocation gene 2 in primary hepatocellular carcinoma[J]. Journal of Third Military Medical University, 2017, 39(7): 685-690. DOI： 10.16016/j.1000-5404.201611153.

摘要

Abstract

Objective

To investigate the expression of B cell translocation gene 2 (BTG2) in the patients with hepatocellular carcinoma (HCC)

and its relationship with postoperative prognosis.

Methods

One hundred and twenty-five patients with hepatocellular carcinoma confirmed pathologically and undergoing surgical treatment in our hospital from January 2012 to December 2014 were enrolled in this study. Among them

101 cases had complete follow-up data. According to the protein expression of BTG2 evaluated by immunohistochemical assay

the subjects were categorized to 3 groups

that is

high (+ +/+ + +)

low (+) and negative expression (-) groups. The correlation of BTG2 expression level with clinical pathological factors and overall survival were analyzed. Twelve pairs of tumor and para-carcinoma tissues were employed to detect the mRNA level of BTG2 by RT-PCR.

Results

In the obtained tumor tissues from 125 case

there 6

13 and 103 cases respectively with high

low and negative expression of BTG2

and the positive rates were 22

41 respectively for the corresponding para-carcinoma tissues. The expression was significantly different between the tumor and para-carcinoma tissues (

Chi

square=28.102

0.001). The RT-PCR results showed that there were 8/12 pairs of tumor and para-carcinoma tissues with BTG2 expression level lower in the tumor tissue than the para-carcinoma tissue. Occurrence of tumor thrombus was significantly associated with BTG2 expression (

Chi

square=8.305

=0.013)

and the low BTG2 expression group had the highest incidences of tumor thrombus. The median overall survival (mOS) was 36 months in the low BTG2 expression group (95%

: 8.436~63.564)

while there was no mOS reached in the high expression and negative groups (Log-Rank

Chi

square=4.512

=0.105). However

the OS was significantly longer in the high than low expression groups (

Chi

square=4.266

=0.039). And there was no significant difference between the high and negative groups (

Chi

square=2.729

=0.099)

or between the low and negative groups (

Chi

square=1.400

=0.237). Stepwise Cox regression analysis showed that differentiation grade

hepatocirrhosis

tumor thrombus and metastasis were independent prognostic factors for OS in the HCC patients.

Conclusion

BTG2 protein is lowly expressed in the HCC tissues

and its high expression indicates better prognosis. It can be used as a potential prognostic factor for HCC.

关键词

Keywords

references

Chen W Zheng R Baade P D Cancer statistics in China, 2015 CA Cancer J Clin 2016 66 2 115 132 10.3322/caac.21338 Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. DOI:10.3322/caac.21338

Park S K Jung Y K Chung D H Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience Korean J Intern Med 2013 28 4 428 438 10.3904/kjim.2013.28.4.428 Park S K, Jung Y K, Chung D H, et al. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience[J]. Korean J Intern Med, 2013, 28(4): 428-438. DOI:10.3904/kjim.2013.28.4.428

Han J H Kim D G Na G H Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma World J Gastroenterol 2014 20 45 17132 17140 10.3748/wjg.v20.i45.17132 Han J H, Kim D G, Na G H, et al. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma[J]. World J Gastroenterol, 2014, 20(45): 17132-17140. DOI:10.3748/wjg.v20.i45.17132

Mao B Zhang Z Wang G BTG2: a rising star of tumor suppressors (review) Int J Oncol 2015 46 2 459 464 10.3892/ijo.2014.2765 Mao B, Zhang Z, Wang G. BTG2: a rising star of tumor suppressors (review)[J]. Int J Oncol, 2015, 46(2): 459-464. DOI:10.3892/ijo.2014.2765

Rouault J P Falette N Guéhenneux F Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway Nat Genet 1996 14 4 482 486 10.1038/ng1296-482 Rouault J P, Falette N, Guéhenneux F, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway[J]. Nat Genet, 1996, 14(4): 482-486. DOI:10.1038/ng1296-482

Gao S S Yang X H Wang M Inhibitory effects of B-cell translocation gene 2 on skin cancer cells via the Wnt/β-catenin signaling pathway Mol Med Rep 2016 14 4 3464 3468 10.3892/mmr.2016.5596 Gao S S, Yang X H, Wang M. Inhibitory effects of B-cell translocation gene 2 on skin cancer cells via the Wnt/β-catenin signaling pathway[J]. Mol Med Rep, 2016, 14(4): 3464-3468. DOI:10.3892/mmr.2016.5596

Choi O R Ryu M S Lim I K Shifting p53-induced senescence to cell death by TIS21(/BTG2/Pc3) gene through posttranslational modification of p53 protein Cell Signal 2016 28 9 1172 1185 10.1016/j.cellsig.2016.05.014 Choi O R, Ryu M S, Lim I K. Shifting p53-induced senescence to cell death by TIS21(/BTG2/Pc3) gene through posttranslational modification of p53 protein[J]. Cell Signal, 2016, 28(9): 1172-1185. DOI:10.1016/j.cellsig.2016.05.014

Dotsikas Y Loukas Y L Improved performance of antigen-HRP conjugate-based immunoassays after the addition of anti-HRP antibody and application of a liposomal chemiluminescence marker Anal Sci 2012 28 8 753 757 10.2116/analsci.28.753 Dotsikas Y, Loukas Y L. Improved performance of antigen-HRP conjugate-based immunoassays after the addition of anti-HRP antibody and application of a liposomal chemiluminescence marker[J]. Anal Sci, 2012, 28(8): 753-757. DOI: 10.2116/analsci.28.753

Wagener N Bulkescher J Macher-Goeppinger S Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients Br J Cancer 2013 108 4 973 982 10.1038/bjc.2012.573 Wagener N, Bulkescher J, Macher-Goeppinger S, et al. Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients[J]. Br J Cancer, 2013, 108(4): 973-982. DOI:10.1038/bjc.2012.573

Zhu W J Huang C Y Li C Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection Asian Pac J Cancer Prev 2013 14 12 7101 7106 10.7314/apjcp.2013.14.12.7101 Zhu W J, Huang C Y, Li C, et al. Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection[J]. Asian Pac J Cancer Prev, 2013, 14(12): 7101-7106. DOI:10.7314/apjcp.2013.14.12.7101

Yu S J Kim Y J Hepatitis B viral load affects prognosis of hepatocellular carcinoma World J Gastroenterol 2014 20 34 12039 12044 10.3748/wjg.v20.i34.12039 Yu S J, Kim Y J. Hepatitis B viral load affects prognosis of hepatocellular carcinoma[J]. World J Gastroenterol, 2014, 20(34): 12039-12044. DOI:10.3748/wjg.v20.i34.12039

Zhang T T Zhao X Q Liu Z Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients Clin Transl Oncol 2016 18 8 831 840 10.1007/s12094-015-1446-0 Zhang T T, Zhao X Q, Liu Z, et al. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients[J]. Clin Transl Oncol, 2016, 18(8): 831-840. DOI:10.1007/s12094-015-1446-0

程树群吴孟超原发性肝癌综合治疗进展中华肝胆外科杂志 2009 15 4 241 243 10.3760/cma.j.issn.1007-8118.2009.04.001 程树群, 吴孟超.原发性肝癌综合治疗进展[J].中华肝胆外科杂志, 2009, 15(4): 241-243. DOI:10.3760/cma.j.issn.1007-8118.2009.04.001.

Cheng S Q Wu M C Advancement in comprehensive treatment of primary hepatocellular carcinoma Chinese Journal of Hepatobiliary Surgery 2009 15 4 241 243 10.3760/cma.j.issn.1007-8118.2009.04.001 Cheng S Q, Wu M C. Advancement in comprehensive treatment of primary hepatocellular carcinoma[J]. Chinese Journal of Hepatobiliary Surgery, 2009, 15(4): 241-243. DOI:10.3760/cma.j.issn.1007-8118.2009.04.001.

Chiang K C Tsui K H Chung L C Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways Sci Rep 2014 4 5511 10.1038/srep05511 Chiang K C, Tsui K H, Chung L C, et al. Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways[J]. Sci Rep, 2014, 4: 5511. DOI:10.1038/srep05511

Lim I K TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule J Cancer Res Clin Oncol 2006 132 7 417 426 10.1007/s00432-006-0080-1 Lim I K. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule[J]. J Cancer Res Clin Oncol, 2006, 132(7): 417-426. DOI:10.1007/s00432-006-0080-1

Sun Q Hang M Guo X Expression and significance of miRNA-21 and BTG2 in lung cancer Tumour Biol 2013 34 6 4017 4026 10.1007/s13277-013-0992-8 Sun Q, Hang M, Guo X, et al. Expression and significance of miRNA-21 and BTG2 in lung cancer[J]. Tumour Biol, 2013, 34(6): 4017-4026. DOI:10.1007/s13277-013-0992-8

Li Y J Dong B K Fan M BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway Int J Clin Exp Pathol 2015 8 10 12410 12418 10.1007/s13277-014-2631-4 Li Y J, Dong B K, Fan M, et al. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway[J]. Int J Clin Exp Pathol, 2015, 8(10): 12410-12418. DOI:10.1007/s13277-014-2631-4

Ficazzola M A Fraiman M Gitlin J Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis Carcinogenesis 2001 22 8 1271 1279 10.1093/carcin/22.8.1271 Ficazzola M A, Fraiman M, Gitlin J, et al. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis[J]. Carcinogenesis, 2001, 22(8): 1271-1279. DOI:10.1093/carcin/22.8.1271

Lee J C Chung L C Chen Y J Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells Cancer Lett 2015 360 2 310 318 10.1016/j.canlet.2015.02.034 Lee J C, Chung L C, Chen Y J, et al. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells[J]. Cancer Lett, 2015, 360(2): 310-318. DOI:10.1016/j.canlet.2015.02.034

Micheli L Ceccarelli M Farioli-Vecchioli S Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes J Cell Physiol 2015 230 12 2881 2890 10.1002/jcp.25038 Micheli L, Ceccarelli M, Farioli-Vecchioli S, et al. Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes[J]. J Cell Physiol, 2015, 230(12): 2881-2890. DOI:10.1002/jcp.25038

Möllerström E Kovács A Lövgren K Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray BMC Cancer 2010 10 296 10.1186/1471-2407-10-296 Möllerström E, Kovács A, Lövgren K, et al. Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray[J]. BMC Cancer, 2010, 10: 296. DOI:10.1186/1471-2407-10-296

Juric D Castel P Griffith M Convergent loss of PTEN leads to clinical resistance to a PI (3) Kα inhibitor Nature 2015 518 7538 240 244 10.1038/nature13948 Juric D, Castel P, Griffith M, et al. Convergent loss of PTEN leads to clinical resistance to a PI (3) Kα inhibitor[J]. Nature, 2015, 518(7538): 240-244. DOI:10.1038/nature13948

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

免疫组化联合半定量法检测淋巴脉管间隙浸润在早期子宫内膜癌的预后价值

70例骨肉瘤临床病理分析及其Notch亚型表达的预后意义

CD68、CD163阳性巨噬细胞在食管癌组织浸润及对预后的影响

磷酸化FGFR1Y654在食管鳞状细胞癌中的表达及临床意义